Scopus BioPharma (SCPS) 10-Q2021 Q3 Quarterly report

Filed: 12 Nov 21, 5:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: absence, alleging, arising, Ashish, assert, assurance, attempt, attorney, Australia, behalf, case, Certificate, claiming, clause, Complaint, complementary, counsel, CRSA, DBA, decision, declaratory, defamatory, demand, demanding, dispute, Disputed, distinctive, diverted, duet, duty, employee, exceeded, expedited, expedition, facilitating, failed, feasibility, fiduciary, fraud, futile, Gibson, Greenspan, inability, indemnification, Indemnified, indemnify, independent, Ira, Joshua, Lamstein, launch, letter, likelihood, longer, Matter, member, merit, mitigate, motion, November, Octoder, original, owner, Platform, preliminary, proceeding, proxy, purported, purportedly, recommendation, repayment, resolve, resolving, response, reversal, Robert, sanctioned, Sanghrajka, satisfactory, Scott, settlement, siRNA, stipulation, stockholder, stop, threatened, timeline, virtue, wasted, wherewithal, wrongfully

Removed: amendment, antigen, cancer, chimeric, commence, contingency, immune, portion, relying, separate, stage

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SCPS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Scopus BioPharma Inc. (the “Company”), on Form 10-Q for the quarter ended September 30, 2021 (the “Report”), as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Joshua R. Lamstein, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)Such Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 12, 2021	By:	/s/ Joshua R. Lamstein
		Joshua R. Lamstein
		Chairman (Principal Executive Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.